Company intelligence / Profile preview

Synovel Laboratory

West Haven, Connecticut, United Statessynovellab.com ↗

Ownership: Private
Development stage: Other

Overview

Synovel Laboratory is an active, private contract research organization specializing in medicinal and process chemistry support for pharmaceutical R&D. The company offers custom synthesis, medicinal chemistry services, process development, DMPK services, and has expertise in antibody-drug conjugates and targeted protein degradation. Its pipeline includes at least one preclinical asset targeting SUMO1 for central nervous system neoplasms. The company also incorporates AI into its drug discovery workflow to accelerate molecular modeling and screening.

Therapeutic areas: Oncology
Modalities: Small moleculeAntibody-drug conjugateTargeted protein degradation (TPD)
Industry: Contract Research Organization

Beyond the preview

Go deeper on Synovel Laboratory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synovel Laboratory.

Explore the full profile